Balance Sheet of Dr Reddys Laboratories ------------------- in Rs. Cr.

------------------Mar '12

Mar '11

12 mths

12 mths

Sources Of Funds
Total Share Capital
Equity Share Capital
Share Application Money
Preference Share Capital
Reserves
Revaluation Reserves
Networth
Secured Loans
Unsecured Loans
Total Debt
Total Liabilities

Application Of Funds
Gross Block
Less: Accum. Depreciation
Net Block
Capital Work in Progress

Investments
Inventories
Sundry Debtors
Cash and Bank Balance
Total Current Assets
Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit
Current Liabilities
Provisions
Total CL & Provisions
Net Current Assets
Miscellaneous Expenses
Total Assets
Contingent Liabilities

84.8
84.8
0
0
6,633.00
0
6,717.80
0.5
1,532.90
1,533.40
8,251.20

84.6
84.6
0
0
5,935.60
0
6,020.20
0.7
1,444.10
1,444.80
7,465.00

Mar '12

Mar '11

12 mths

12 mths

3,507.80
1,611.00
1,896.80
637.6
2,477.70
1,326.70
1,943.50
93.10
3,363.30
1,291.40
755.90

3,025.00
1,334.00
1,691.00
570.4
2,462.00
1,063.20
1,770.50
66.20
2,899.90
1,663.80
0.00

5,410.60

4,563.70

0
1,534.30
637.2

0
1,565.20
256.90

2,171.50

1,822.10

3,239.10
0
8,251.20

2,741.60
0
7,465.00

2,018.90

1,526.00

Book Value (Rs)

396.19

355.69

3,363.30

1,829.00
494.30

497.50

8,375.40

5,012.10
3,239.10

3,270.20

2,833.70

3,239.10
1,334.70
1,829.00
494.30
2,171.50
1,191.80
124.20

1,334.70
5,012.10
0.225548418

Profit & Loss account of Dr Reddys Laboratories

------------------- in Rs. Cr. ------------------Mar '12

Mar '11

12 mths

12 mths

Income
Sales Turnover
Excise Duty
Net Sales
Other Income
Stock Adjustments
Total Income
Expenditure
Raw Materials
Power & Fuel Cost
Employee Cost
Other Manufacturing Expenses

Selling and Admin Expenses

Miscellaneous Expenses
Preoperative Exp Capitalised
Total Expenses

Operating Profit
PBDIT

Interest
PBDT
Depreciation
Other Written Off
Profit Before Tax
Extra-ordinary items
PBT (Post Extra-ord Items)

Tax
Reported Net Profit
Total Value Addition
Preference Dividend
Equity Dividend
Corporate Dividend Tax
Per share data (annualised)
Shares in issue (lakhs)

6,780.20
93.9
6,686.30
-191.90
104.8
6,599.20

5,285.80
97.3
5,188.50
117.00
79
5,384.50

2,122.90
177.5
831.2
163.1

1,749.50
144.6
702.7
129.5

1,554.40

1,256.70

80.30
0
4,929.40

65.00
0
4,048.00

Mar '12

Mar '11

12 mths

12 mths

1,861.70

1,219.50

1,669.80

1,336.50

69.2

9.9

1,600.60
301.1
40.3
1,259.20
-0.3
1,258.90

1,326.60
247.9
26.8
1,051.90
-0.4
1,051.50

346.8
912.4

158.5
893.4

2,806.50
0
233.1
37.8

2,298.50
0
190.4
115.2

1,695.60

1,692.53

Earning Per Share (Rs)

Equity Dividend (%)
Book Value (Rs)

53.81
275
396.19

52.78
225
355.69

28%
-3%
29%

1,669.80
1,861.70

Reinvestment
ROCE
Expected growth rate

86%
23%
57%
19.362098724024400%

16%

0.225633257 0.163295
52.66%
46%

8,251.20
23%
118.80%
2.13%
Interest coverage ratio

WC=

19%
26.90

1604.712
359.47

1245.24

13%

DPS
EPS
payout ratio
retention ratio

13.75
53.81
26%
74%

Cash Flow of Dr Reddys Laboratories

------------------- in Rs. Cr. ------------------Mar '12

12 mths

Net Profit Before Tax

Net Cash From Operating Activities
Net Cash (used in)/from Investing Activities

1259.2
1403
-423.5

Net Cash (used in)/from Financing Activities

Net (decrease)/increase In Cash and Cash Equivalents
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalents

-194.9
784.6
64.4
849

-- in Rs. Cr. ------------------Mar '11

12 mths
1051.9
246.3
-613
61
-305.7
371.9
66.2

Application Of Funds
Gross Block
Less: Accum. Depreciation
Net Block
Capital Work in Progress
Investments

3,507.80
1,611.00
1,896.80
637.6
2,477.70

3,025.00
1,334.00
1,691.00
570.4
2,462.00

Inventories
Sundry Debtors
Cash and Bank Balance

1,326.70
1,943.50
93.1

1,063.20
1,770.50
66.2

3,363.30

2,899.90

1,291.40
755.9
5,410.60
0

1,663.80
0
4,563.70
0

1,534.30

1,565.20

Provisions
Total CL & Provisions
Net Current Assets
Miscellaneous Expenses
Total Assets

637.2
2,171.50
3,239.10
0
8,251.20

256.9
1,822.10
2,741.60
0
7,465.00

Contingent Liabilities
Book Value (Rs)

2,018.90
396.19

1,526.00
355.69

Total Current Assets

Loans and Advances
Fixed Deposits
Total CA, Loans & Advances
Deffered Credit

Current Liabilities

2,425.70
1,110.10
1,315.60
745.4
2,652.70

2,157.30
946.5
1,210.80
411.2
1,865.10

1,750.21
762.8
987.41
245.71
2,080.71

897.4
1,060.50
47.9

735.1
1,419.70
84.3

640.93
897.71
67.19

2,005.80

2,239.10

1,321.40
320.1
3,647.30
0

1,331.20
300.1
3,870.40
0

1,272.02
470.15
3,348.00
0

1,543.80

1,163.30

786.36

339.4
1,883.20
1,764.10
0
6,477.80

294.8
1,458.10
2,412.30
0
5,899.40

601.38
1,387.74 Revenues=
1,960.26
0 %=
5,274.09

2,016.10
350.3

1,934.80
312.17

1,892.55
286.12

1,605.83 WC=

3,270.20

1,735.90
Change in WC=

1,534.30
6,686.30
26%
24%

2,833.70

1,957.90 2,154.80 1,538.64

1,268.50

414.10

991.50

752.28

467.40

854.40

-577.40

239.22

1,543.80 1,163.30

786.36

1,565.20
5,188.50

4,395.60

3,999.50

3,343.89

24%

9%

25%

22%